Clinical Trials in Houston

Showing 4161-4180 of 17,885 trials

28-Day Study of SAGE-718 on Functioning Capacity in Participants With Huntington's Disease

NCT05358821

The primary purpose of this study is to assess the magnitude of the baseline difference between participants with early Huntington's Disease (HD) and healthy participants (HP) with respect to measures of cognitive performance.

Huntington Disease

Supernus Pharmaceuticals, Inc.69 participantsStarted May 2022

Birmingham, Alabama, United States • Los Alamitos, California, United States • Englewood, Colorado, United States +11 more locations

COMPLETEDNA< 1 mile

Cross-Seal Closure Device IDE Trial - Study of the Cross-SealTM Suture-Mediated Vascular Closure Device System

NCT03756558

This study evaluates the safety and effectiveness of the Cross-Seal vascular closure device in gaining post procedure hemostasis in subjects undergoing interventional procedures requiring an 8 to 18 french size introducer sheath.

Vascular Closure

Terumo Medical Corporation147 participantsStarted Aug 2019

Denver, Colorado, United States • Jacksonville, Florida, United States • Tampa, Florida, United States +17 more locations

28-Day Study of SAGE-718 on Functioning Capacity in Participants With Huntington's Disease

Cross-Seal Closure Device IDE Trial - Study of the Cross-SealTM Suture-Mediated Vascular Closure Device System

Find Trials by Condition in Houston

Patient Reported Outcomes With WaveLight Plus LASIK

Safety Study of a Vaccine to Help Protect Against Lyme Disease in Healthy Children

Study to Evaluate the Safety and Efficacy of Pegvaliase in Adolescents (Ages 12-17) With Phenylketonuria

PROmotion of COVID-19 BOOSTer VA(X)Ccination in the Emergency Department - PROBOOSTVAXED

Histological Evaluation in the Efficacy of GentleWave in Root Canal Pulp Tissue Debridement and Disinfection of Difficult to Reach Areas in Mandibular Human Molars II. An In-vivo Study.

Evaluate the Safety and Effectiveness of iSTAR Medical's MINIject™ Implant for Lowering Intraocular Pressure (IOP) in Subjects With Primary Open-angle Glaucoma.

OMEGA: Outcome Measures in Eosinophilic Gastrointestinal Disorders Across the Ages

Navigating the Transition to Adulthood: A Dual Language Mobile App for Latino Youth With ASD and Their Families

A Neurosensory Account of Anxiety and Stress (Study 1)

Study to Evaluate SAGE-547 Injection as Adjunctive Therapy for the Treatment of Super-Refractory Status Epilepticus

A Study in Adults to Investigate the Impact of Mild, Moderate, and Severe Hepatic Impairment on Pharmacokinetics of Venglustat Compared to Participants With Normal Hepatic Function

A Dose-Range Study of Aleniglipron (GSBR-1290) in Participants Living With Obesity or Overweight With at Least One Weight-related Comorbidity

Phase 1a/1b Study of TPST-1495 as a Single Agent and in Combination With Pembrolizumab in Subjects With Solid Tumors

A Study of Brigatinib Compared to Alectinib in Adults With Non-Small-Cell Lung Cancer

A Study to Evaluate the Safety and Tolerability of SAGE-718 in Participants With Parkinson's Disease Mild Cognitive Impairment (PD-MCI)

Pharmacodynamic EffIcacy and Clinical Benefit of AT 007 in Patients With Sorbitol Dehydrogenase (SORD) Deficiency

Use of Stromal Vascular Fraction in Multiple Sclerosis

Use of Autologous, Adult Adipose-Derived Stem/Stromal Cells In Chronic Lung Disorders